Abstract Objectives To develop the European League Against Rheumatism (EULAR)
recommendations for conducting clinical studies and/or clinical trials in systemic vasculitis …

Wegener's granulomatosis, microscopic polyangiitis, and Churg-Strauss syndrome are small-
to medium-vessel vasculitides linked by overlapping pathology and the presence of …

Objective To reevaluate the efficacy and safety of adjunctive low‐dose methotrexate (MTX)
in giant cell arteritis (GCA). Methods An individual patient data meta‐analysis of 3 …

Objective To estimate the annual incidence, prevalence, and mortality of antineutrophil
cytoplasmic autoantibody (ANCA)–associated vasculitis (AAV) and its subsets …

Objective To report baseline data on 180 patients with Wegener's granulomatosis (WG)
enrolled in the WG Etanercept Trial (WGET), and to examine demographic and clinical …

BACKGROUND: The pathogenic significance of antineutrophilic cytoplasmic antibodies
(ANCA) in Wegener's granulomatosis is controversial. Their presence is influenced by the …

Objective To identify genetic determinants of granulomatosis with polyangiitis
(Wegener's)(GPA). Methods We carried out a genome‐wide association study (GWAS) of …

Background The majority of patients with Wegener's granulomatosis have disease flares
after conventional medications are tapered. There is no consistently safe, effective treatment …

Background: The utility of antineutrophil cytoplasmic antibody (ANCA) levels to guide the
management of patients with Wegener granulomatosis remains controversial. Objective: To …

Wegener's granulomatosis (WG) is a systemic inflammatory disease whose histopathologic
features often include necrosis, granuloma formation, and vasculitis of small-to-medium …